Repository logo
Institutional Digital Repository
Shreenivas Deshpande Library, IIT (BHU), Varanasi

Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer

dc.contributor.authorKumar, Rahul
dc.contributor.authorRanjan Srivastava, Vinish
dc.contributor.authorMahapatra, Supratim
dc.contributor.authorDkhar, Daphika S.
dc.contributor.authorKumari, Rohini
dc.contributor.authorDarshna
dc.contributor.authorPrerna, Kumari
dc.contributor.authorDubey, Vikash Kumar
dc.contributor.authorChandra, Pranjal
dc.date.accessioned2024-02-05T06:39:50Z
dc.date.available2024-02-05T06:39:50Z
dc.date.issued2023-01-16
dc.descriptionThis paper published with affiliation IIT (BHU), Varanasi in Open Access Mode.en_US
dc.description.abstractThe focus of this research is to design a bioengineered drug delivery vehicle that is efficient in anti-cancer drug delivery in a controlled manner. The experimental work focuses on constructing a methotrexate-loaded nano lipid polymer system (MTX-NLPHS) that can transport methotrexate (MTX) in MCF-7 cell lines in a controlled manner through endocytosis via phosphatidylcholine. In this experiment, MTX is embedded with polylactic-co-glycolic acid (PLGA) in phosphatidylcholine, which acts as a liposomal framework for regulated drug delivery. Scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and dynamic light scattering (DLS) were utilized to characterize the developed nanohybrid system. The particle size and encapsulation efficiency of the MTX-NLPHS were found to be 198 ± 8.44 nm and 86.48 ± 0.31 %, respectively, which is suitable for biological applications. The polydispersity index (PDI) and zeta potential of the final system were found to be 0.134 ± 0.048 and-28 ± 3.50 mV, respectively. The lower value of PDI showed the homogenous nature of the particle size, whereas higher negative zeta potential prevented the system from agglomeration. An in vitro release kinetics was conducted to see the release pattern of the system, which took 250 h for 100% drug release This kind of system may carry the drug for a long time in the circulatory system and prevent the drug discharge. Other cell culture assays such as 3-(4, 5-dimethyl thiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) and reactive oxygen species (ROS) monitoring were used to see the effect of inducers on the cellular system. MTT assay showed cell toxicity of MTX-NLPHS reduced at the lower concentration of the MTX, however, toxicity increased at the higher concentration of the MTX as compared to free MTX. ROS monitoring c revealed more scavenging of ROS using MTX-NLPHS as compared to free MTX. Confocal microscopy suggested the MTX-NLPHS induced more nuclear elongation with cell shrinkage comparatively.en_US
dc.identifier.issn22067418
dc.identifier.urihttps://idr-sdlib.iitbhu.ac.in/handle/123456789/2808
dc.language.isoenen_US
dc.publisherIvyspring International Publisheren_US
dc.relation.ispartofseriesNanotheranostics;7
dc.subjectdrug deliveryen_US
dc.subjectlipiden_US
dc.subjectMCF-7 cellsen_US
dc.subjectmethotrexateen_US
dc.subjectnanohybrid systemen_US
dc.subjecttheranosticsen_US
dc.titleDrug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Canceren_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Drug-Encapsulated-LipidPolymeric-Nanohybrid-as-a-Chemotherapeutic-Platform-of-CancerNanotheranostics.pdf
Size:
4.82 MB
Format:
Adobe Portable Document Format
Description:
Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: